Koa Health is the leading global provider offering evidence-based, personalized, integrated solutions that deliver mental health for everyone. Available to more than 3 million users worldwide, Koa Health leverages deep clinical expertise, research and technology to deliver effective and accessible care that adapts to users’ unique circumstances, leading to lasting behavior change and positive health outcomes.
Curebase is a leading provider of decentralized clinical research software and services for digital therapeutics. Curebase enables any patient and any healthcare provider to be part of a clinical study, accelerating enrollment and enabling novel study designs with diverse populations. Curebase operates as a complete eClinical software platform, virtual research site, and full-service CRO.
Decimal.health is a specialized digital health consulting firm that creates and implements
strategies to launch and grow digital health products and services. Through our deep network
and expertise in US healthcare delivery and regulations, we help digital health businesses
navigate the complex DTx and FDA regulatory path and gain traction with investors and
BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Every line of code of our BrightInsight Platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement. The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with global security, privacy and regulatory requirements. Deployed as a managed service, the platform accelerates time to market for biopharma and medtech companies, reduces the cost of implementation and maintenance versus a custom solution, and scales across products and global markets.
DTxCC: a boutique consultancy focused solely on Digital Therapeutics and Digital Health commercialization
We specialize in go-to-market strategy development:
– Market Access and Reimbursement
– Business models development
– Data monetization
Our Payer Advisory Council provides actionable insight
Custom qualitative research
– One-one-one interviews
Advisory board meetings
– Live face-to-face meetings
Oblon is one of the largest law firms in the U.S. focused exclusively on patent law. For 50+ years, we’ve been recognized as an industry leader in securing, leveraging and enforcing patents for companies worldwide. Oblon provides a range of IP services from patent prosecution, litigation, and PTAB proceedings to trademarks and designs.
Following extensive research with the industry, we know that whilst some want to meet virtually this year, most are keen to meet in person.
This year we will be meeting in-person, and offering an online option for those who are unable to join us on the West coast. Your safety is our top priority. To learn about the steps we are taking to make this summit more Covid secure, take a look at our protocols:
The time has come to meet in-person once again! Join your peers for live presentations, engaging discussions and face-to-face networking. Step away from the screen for 3 days of industry-defining discussions and catch up with old and make new connections within the field. With some of the audience tuning in virtually, use our dedicated session to network with industry leaders from across the globe.
DTx West 2022 is back with a bang! Bringing you 3 full days of cutting-edge content and an industry leading speaker faculty, this event provides you with a one-stop shop of all things digital therapeutics ensuring you leave the event with key takeaways and the knowledge to accelerate your own digital journey. We’ve got a lot to catch up on and DTx West has got you covered!
Can’t attend in person? Tune in to DTx West online and catch every presentation and panel discussion as it’s streamed live from Boston. Dive into the networking world to connect with both online and in-person attendees. We’ve also made sure you can interact live with speakers, ensuring all of your burning questions get answered by the experts!
“Digital Therapeutics hold tremendous potential to address unmet medical needs in patients, especially now. Yet “it will take a village” to adopt this new category of medicine in our routine healthcare systems and practices. And many thanks to DTx for offering the village community a place to convene – both in person and online”
“The digital therapeutics industry as a whole is incredibly collaborative, and the DTx conference series provides the ideal platform for all stakeholders to come together, share ideas, and leave with the ability to have the most impact on patients’ lives”
“The DTx Series helped shape the conversations in this new digital health category from the beginning. All the key players show up to continue the conversation and I am looking forward to the virtual experience this year. I wouldn’t miss it for the world”
“DTx East was by far the best digital conference I’ve been to”
“Great conference, excellent content, and the virtual experience was just like being in-person! Can’t wait for the next one!”
“DTx conferences are excellent places to collaborate with top leaders and stay current on the often complex and evolving trends shaping our investments – all while being part of a passionate, growing community of entrepreneurs.”
2022 Speaker Faculty
The Honorable Dr. David J. Shulkin was the ninth Secretary of the US Department of
Veterans Affairs in the Trump Administration and VA’s Under Secretary of Health in the
Obama Administration. As such, Secretary Shulkin was the only member of the Cabinet
to have served both Presidents and to have been confirmed by the US Senate by a vote of
Secretary Shulkin is a widely respected healthcare executive having served as chief
executive of leading hospitals and health systems including Beth Israel in New York
City, Morristown Medical Center in Northern NJ and currently he serves as Executive
Vice President at Sanford Health one of the country’s largest rural healthcare systems.
Secretary Shulkin is a board-certified internist. He received his medical degree from the
Medical College of Pennsylvania, his internship at Yale University School of Medicine,
and a residency and Fellowship in General Medicine at the University of Pittsburgh
Presbyterian Medical Center. He received advanced training in outcomes research and
economics as a Robert Wood Johnson Foundation Clinical Scholar at the University of
Over his career Secretary Shulkin has been named “One Hundred Most Influential
People in American Healthcare” by Modern Healthcare. He continues to advocate on
behalf of the country’s veterans by serving on the board of numerous nonprofits that
serve veterans, is the host of the popular Policy Vets Podcast, and is the author of the
recent book, “It Shouldn’t Be This Hard to Serve Your Country: Our Broken Government
and the Plight of Veterans”.
Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®. Since joining WellDoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. He holds an MS and a PhD in electrical and computer engineering, and an MBA from Carnegie Mellon University.
Dr. Parks’ research focuses on self-help methods for increasing well-being via books and digital technology. Acacia is the Chief Behavioral Health Officer at Found. Prior to tis, Acacia was the Chief Scientist for tech startup Happify, which brings the cutting edge in research-based well-being interventions to large businesses, health plans, and consumers. Her research spans across the whole spectrum of wellness, from non-distressed consumers to stressed employees, sufferers of chronic health conditions, and individuals with depression and/or anxiety. She works to pioneer new methodology in the study of digital therapeutics, especially when it comes to outcomes assessment. Her work has been published in peer-reviewed journals, and in addition to editing three books, she is also an Associate Editor at the Journal of Positive Psychology.
Dr. Rosner is an Associate Professor of Medicine and an informaticist and digital health researcher in the Center for Clinical Informatics and Improvement Research (CLIIR).
Dr. Rosner holds a PhD in engineering from the University of Minnesota and spent a decade as a part time Hospitalist at Kaiser Permanente prior to joining UCSF.
Julia Strandberg serves as Chief Commercial Officer at Pear Therapeutics, responsible for crafting and implementing patient-, clinician-, and payer-centered strategies to accelerate the adoption of Prescription Digital Therapeutics (PDTs). She draws on extensive experience in developing and commercializing innovative medical technologies. From medical devices and RFID technologies, to consumer electronics, she has championed novel technologies and innovative business models to transform healthcare and advance the healthcare industry.
Prior to joining Pear, Julia served as Medtronic’s Vice President & General Manager for the Health Informatics & Monitoring division. She also has served as Vice President of Global Marketing for the Patient Monitoring franchise for Covidien. Julia joined Covidien in the Strategy & Portfolio group for Sleep Diagnostics and Therapy. She began her career at 3M Company, where she held multiple engineering and marketing positions in the Optical Systems and Track and Trace solutions division.
She earned her MBA from University of Minnesota, Carlson School of Management, and her undergraduate degree in Chemical Engineering at Purdue University.
Kamal is an industry leader with 15+ years of experience in digital health from a provider
perspective, most recently at MassGeneral Brigham, with background in digital health strategy,
product design and clinical research and validation. Kamal has developed and implemented
100+ digital health programs and is widely published in the value digital health can bring to
Steve brings nearly 15 years of healthcare experience working with pharma brands, CPG wellness, and change management platforms. Successfully navigating through such a highly-regulated industry brings its own unique challenges, but he has the experience to tackle them head-on and knows that digital has the power to transform the healthcare landscape and bring ambitious new ideas to life.
Ryan is a healthcare executive that has extensive experience commercializing innovative HealthTech solutions. He’s currently Vice President of Growth at Wellsheet, a company working with health systems across the US providing a cloud-based, predictive workflow designed for providers at the point of care that substantially improves productivity and reduces clinician burnout. He previously led the commercialization of the Podimetrics SmartMat for four years, a remote patient monitoring solution capable of detecting 97% of diabetic foot ulcers five weeks before clinical presentation. During this time, Ryan secured contracts with multiple health systems and health plans, including a national roll-out with the Veterans Health Administration. Ryan holds an MBA from Rice University and a BS in Naval Architecture from Webb Institute.
Cyndi Williams is founder and CEO of Quin, a digital therapeutic that uses game narrative theory to treat diabetes distress and improve diabetes outcomes. Before founding Quin she was a managing director at ThoughtWorks, a global $500M software company, heading up the UK business and the global software products division. She spent her early career as a software engineer at Sun Microsystems and has BSc in Chemical Engineering from Northwestern University.
Adam is Director of Clinical Operations at Curebase, overseeing all Curebase’s clinical trials, including digital therapeutics. Adam has a range of therapeutic and research experience. He began his career as a coordinator and transitioned into monitoring and project management roles of increasing responsibility within CROs, academia, and pharma.
Adam received a master’s in clinical research from George Washington University and is active in his professional community.
For those of you attending in-person, we will be coming together in at the San Mateo Marriott this February. Working with the venue and following the guidelines from local and national authorities, we have developed robust COVID-19 mitigation protocols.
This means at this point spaces are limited to meet social distancing guidelines. This may change as we move closer to the event and we will notify you of any changes via the website.
For online attendees, we will be running the event on the Hopin conference platform. Not only will you be able to view all the content as it happens, but you will also be able to network with both your fellow online attendees, as well as those in-person. You’ll also be able to pose your questions to the speaker faculty directly through the platform.
Partner with us
The DTx summits are the premier events for senior executives from DTx companies, Pharma, Investors, HCPs and Payers.
DTx West 2022 is the ninth summit in the US DTx series. We are expecting 300 people between the online and in-person audience Summit, which is what our attendees and partners tell us is the optimum size.
We believe that getting the right mix of partners is critical for a successful summit for you and our attendees. The DTx summit provides a rare opportunity to showcase your business to a world-class audience.
You will be impressed with our service and truthfulness. We will be honest with you throughout the process from deciding which option is right for you to delivery on-site.
Get in touch today to learn more and avoid missing out!
Register for the Event
For pricing and booking options please click the button to go to the registration page.